Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34391772.
- Also identified by DOI 10.1053/j.gastro.2021.08.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Metaplasia and dysplasia in the corpus are reportedly derived from de-differentiation of chief cells. However, the cellular origin of metaplasia and cancer remained uncertain. Therefore, we investigated whether pepsinogen C (PGC) transcript-expressing cells represent the cellular origin of metaplasia and cancer using a novel Pgc-specific CreERT2 recombinase mouse model. We generated a Pgc-mCherry-IRES-CreERT2 (Pgc-CreERT2) knock-in mouse model. Pgc-CreERT2/<sup>+</sup> and Rosa-EYFP mice were crossed to generate Pgc-CreERT2/Rosa-EYFP (Pgc-CreERT2/YFP) mice. Gastric tissues were collected, followed by lineage-tracing experiments and histologic and immunofluorescence staining. We further established Pgc-CreERT2;Kras<sup>G12D/+</sup> mice and investigated whether PGC transcript-expressing cells are responsible for the precancerous state in gastric glands. To investigate cancer development from PGC transcript-expressing cells with activated Kras, inactivated Apc, and Trp53 signaling pathways, we crossed Pgc-CreERT2/<sup>+</sup> mice with conditional Kras<sup>G12D</sup>, Apc<sup>flox</sup>, Trp53<sup>flox</sup> mice. Expectedly, mCherry mainly labeled chief cells in the Pgc-CreERT2 mice. However, mCherry was also detected throughout the neck cell and isthmal stem/progenitor regions, albeit at lower levels. In the Pgc-CreERT2;Kras<sup>G12D/+</sup> mice, PGC transcript-expressing cells with Kras<sup>G12D/+</sup> mutation presented pseudopyloric metaplasia. The early induction of proliferation at the isthmus may reflect the ability of isthmal progenitors to react rapidly to Pgc-driven Kras<sup>G12D/+</sup> oncogenic mutation. Furthermore, Pgc-CreERT2;Kras<sup>G12D/+</sup>;Apc<sup>flox/flox</sup> mice presented intramucosal dysplasia/carcinoma and Pgc-CreERT2;Kras<sup>G12D/+</sup>;Apc<sup>flox/flox</sup>;Trp53<sup>flox/flox</sup> mice presented invasive and metastatic gastric carcinoma. The Pgc-CreERT2 knock-in mouse is an invaluable tool to study the effects of successive oncogenic activation in the mouse corpus. Time-course observations can be made regarding the responses of isthmal and chief cells to oncogenic insults. We can observe stomach-specific tumorigenesis from the beginning to metastatic development.
Medical subject headings
- Cell Proliferation
- Cell Transformation, Neoplastic
- Chief Cells, Gastric
- Integrases
- Pepsinogen C
- Precancerous Conditions
- Proto-Oncogene Proteins p21(ras)
- Stomach Neoplasms
- Transcriptional Activation